Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 6

Results: 24

Supreme Court and the Practice of Oncology.
Published in:
2022
By:
- Chabner, Bruce A;
- Bates, Susan E
Publication type:
Editorial
Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 441, doi. 10.1093/oncolo/oyac075
By:
- Martin, James M;
- Handorf, Elizabeth A;
- Montero, Alberto J;
- Goldstein, Lori J
Publication type:
Article
Update to "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors".
Published in:
Oncologist, 2022, v. 27, n. 6, p. e534, doi. 10.1093/oncolo/oyac068
By:
- Zhu, Mojun;
- Bekaii-Saab, Tanios
Publication type:
Article
Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e533, doi. 10.1093/oncolo/oyac063
By:
- Villani, Alessia;
- Fabbrocini, Gabriella;
- Costa, Claudia;
- Potestio, Luca;
- Scalvenzi, Massimiliano
Publication type:
Article
Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 462, doi. 10.1093/oncolo/oyac061
By:
- Nazha, Bassel;
- Zhuang, Tony Z;
- Dada, Hiba I;
- Drusbosky, Leylah M;
- Brown, Jacqueline T;
- Ravindranathan, Deepak;
- Carthon, Bradley C;
- Kucuk, Omer;
- Goldman, Jamie;
- Master, Viraj A;
- Bilen, Mehmet Asim
Publication type:
Article
One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e524, doi. 10.1093/oncolo/oyac060
By:
- Watanabe, Daichi;
- Iihara, Hirotoshi;
- Fujii, Hironori;
- Makiyama, Akitaka;
- Nishida, Shohei;
- Suzuki, Akio
Publication type:
Article
Signal Detection of Adverse Events Associated with Trastuzumab in a Cohort of Elderly Patients with Breast Cancer.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 434, doi. 10.1093/oncolo/oyac059
By:
- Polychronopoulou, Efstathia;
- Giordano, Sharon H;
- Chou, Lin-Na;
- Yu, Xiaoying;
- Kuo, Yong-Fang
Publication type:
Article
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e484, doi. 10.1093/oncolo/oyac051
By:
- Pasello, Giulia;
- Lorenzi, Martina;
- Calvetti, Lorenzo;
- Oliani, Cristina;
- Pavan, Alberto;
- Favaretto, Adolfo;
- Palazzolo, Giovanni;
- Giovanis, Petros;
- Zustovich, Fable;
- Bonetti, Andrea;
- Bernardi, Daniele;
- Mandarà, Marta;
- Aprile, Giuseppe;
- Crivellaro, Giovanna;
- Sinigaglia, Giusy;
- Tognazzo, Sandro;
- Morandi, Paolo;
- Bortolami, Alberto;
- Marino, Valentina;
- Bonanno, Laura
Publication type:
Article
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 453, doi. 10.1093/oncolo/oyac048
By:
- Stein, Mark N;
- Fong, Lawrence;
- Tutrone, Ronald;
- Mega, Anthony;
- Lam, Elaine T;
- Parsi, Megan;
- Vangala, Surya;
- Gutierrez, Andres A;
- Haas, Naomi B
Publication type:
Article
Doctor Will FaceTime You Now: Commentary on Telehealth in Cancer Care.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 428, doi. 10.1093/oncolo/oyac044
By:
- Feinberg, Jacqueline;
- Sonoda, Yukio
Publication type:
Article
Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e518, doi. 10.1093/oncolo/oyac029
By:
- Paluri, Ravi;
- Laursen, Ashley;
- Gaeta, Joseph;
- Wang, Shu;
- Surinach, Andy;
- Cockrum, Paul
Publication type:
Article
Perception of Telehealth During the COVID-19 Pandemic Among Survivors of Gynecologic Cancer.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 512, doi. 10.1093/oncolo/oyac041
By:
- Quam, Nicholas;
- Stenzel, Ashley E;
- Brown, Katherine;
- Jewett, Patricia;
- Parsons, Helen M;
- Hui, Jane;
- Ghebre, Rahel G;
- Blaes, Anne;
- Teoh, Deanna;
- Vogel, Rachel I
Publication type:
Article
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 501, doi. 10.1093/oncolo/oyac040
By:
- Gantzer, Justine;
- Davidson, Guillaume;
- Vokshi, Bujamin;
- Weingertner, Noëlle;
- Bougoüin, Antoine;
- Moreira, Marco;
- Lindner, Véronique;
- Lacroix, Guillaume;
- Mascaux, Céline;
- Chenard, Marie-Pierre;
- Bertucci, François;
- Davidson, Irwin;
- Kurtz, Jean-Emmanuel;
- Sautès-Fridman, Catherine;
- Fridman, Wolf H;
- Malouf, Gabriel G
Publication type:
Article
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e471, doi. 10.1093/oncolo/oyac036
By:
- Kang, Cyra Y;
- Duarte, Samantha E;
- Kim, Hye Sung;
- Kim, Eugene;
- Park, Jonghanne;
- Lee, Alice Daeun;
- Kim, Yeseul;
- Kim, Leeseul;
- Cho, Sukjoo;
- Oh, Yoojin;
- Gim, Gahyun;
- Park, Inae;
- Lee, Dongyup;
- Abazeed, Mohamed;
- Velichko, Yury S;
- Chae, Young Kwang
Publication type:
Article
Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 430, doi. 10.1093/oncolo/oyab074
By:
- Trojan, Jörg;
- Hoffmeister, Albrecht;
- Neu, Bruno;
- Kasper, Stefan;
- Dechêne, Alexander;
- Jürgensen, Christian;
- Schirra, Jörg;
- Jakobs, Ralf;
- Palmer, Dan;
- Selbo, Pål k.;
- Olivecrona, Hans;
- Finnesand, Lena;
- Høgset, Anders;
- Walday, Per;
- Sturgess, Richard
Publication type:
Article
FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 493, doi. 10.1093/oncolo/oyac042
By:
- Le, Robert Q;
- Wang, Xin;
- Zhang, Hongfei;
- Li, Hongshan;
- Przepiorka, Donna;
- Vallejo, Jonathon;
- Leong, Ruby;
- Ma, Lian;
- Goldberg, Kirsten B;
- Pazdur, Richard;
- Theoret, Marc R;
- Claro, Angelo De
Publication type:
Article
Real-world Impact of Age at Diagnosis on Treatment Patterns and Survival Outcomes of Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 469, doi. 10.1093/oncolo/oyac028
By:
- Elias, Rawad;
- Cockrum, Paul;
- Surinach, Andy;
- Wang, Shu;
- Chu, Bong Chul;
- Shahrokni, Armin
Publication type:
Article
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075
By:
- Jun, Tomi;
- Hahn, Noah M;
- Sonpavde, Guru;
- Albany, Constantine;
- MacVicar, Gary R;
- Hauke, Ralph;
- Fleming, Mark;
- Gourdin, Theodore;
- Jana, Bagi;
- Oh, William K;
- Taik, Patricia;
- Wang, Huan;
- Varadarajan, Ajay Ramakrishnan;
- Uzilov, Andrew;
- Galsky, Matthew D
Publication type:
Article
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 476, doi. 10.1093/oncolo/oyac035
By:
- Mack, Philip C;
- Klein, Michael I;
- Ayers, Kristin L;
- Zhou, Xiang;
- Guin, Sunny;
- Fink, Marc;
- Rossi, Michael;
- AI-Kateb, Hussam;
- O'Connell, Timmy;
- Hantash, Feras M;
- Oh, William K;
- Newman, Scott;
- Schadt, Eric E;
- Chen, Rong;
- Hirsch, Fred R
Publication type:
Article
Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.
Published in:
Oncologist, 2022, v. 27, n. 6, p. 447, doi. 10.1093/oncolo/oyab072
By:
- Duan, Heying;
- Ferri, Valentina;
- Fisher, George Albert;
- Shaheen, Shagufta;
- Davidzon, Guido Alejandro;
- Iagaru, Andrei;
- Aparici, Carina Mari
Publication type:
Article
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).
Published in:
Oncologist, 2022, v. 27, n. 6, p. e494, doi. 10.1093/oncolo/oyab070
By:
- Lee, Seohyuk;
- Ma, Chao;
- Zhang, Sui;
- Ou, Fang-Shu;
- Bainter, Tiffany M;
- Niedzwiecki, Donna;
- Saltz, Leonard B;
- Mayer, Robert J;
- Whittom, Renaud;
- Hantel, Alexander;
- Benson, Al;
- Atienza, Daniel;
- Kindler, Hedy;
- Gross, Cary P;
- Irwin, Melinda L;
- Meyerhardt, Jeffrey A;
- Fuchs, Charles S
Publication type:
Article
Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e453, doi. 10.1093/oncolo/oyab076
By:
- Zhang, Yang;
- Luo, Fan;
- Ma, Yu-Xiang;
- Liu, Qian-Wen;
- Yang, Yun-Peng;
- Fang, Wen-Feng;
- Huang, Yan;
- Zhou, Ting;
- Li, Jin;
- Pan, Hong-Ming;
- Yang, Lei;
- Qin, Shu-Kui;
- Zhao, Hong-Yun;
- Zhang, Li
Publication type:
Article
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e506, doi. 10.1093/oncolo/oyab069
By:
- Nakayama, Izuma;
- Takahari, Daisuke;
- Shimozaki, Keitaro;
- Chin, Keisho;
- Wakatsuki, Takeru;
- Ogura, Mariko;
- Ooki, Akira;
- Kamiimabeppu, Daisaku;
- Osumi, Hiroki;
- Shinozaki, Eiji;
- Yamaguchi, Kensei
Publication type:
Article
Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.
Published in:
Oncologist, 2022, v. 27, n. 6, p. e463, doi. 10.1093/oncolo/oyab068
By:
- Yuan, Shumin;
- Fu, Qiang;
- Zhao, Lingdi;
- Fu, Xiaomin;
- Li, Tiepeng;
- Han, Lu;
- Qin, Peng;
- Ren, Yingkun;
- Huo, Mingke;
- Li, Zhimeng;
- Lu, Chaomin;
- Yuan, Long;
- Gao, Quanli;
- Wang, Zibing
Publication type:
Article